Neurological and psychiatric disorders as a neuroglial failure

Periodicum Biologorum

Volumn 116, Issue 2, 2014, Pages 115-124

  Verkhratsky, Alexei ^a,b,c   Parpura, Vladimir ^d,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Rijeka   (Croatia)

Author keywords

Astrocyte; Microglia; Neurodegeneration; Neuroglia; Neurological diseases; NG2 glia; Oligodendrocyte; Psychiatric diseases; Reactive gliosis

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; KYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID; PROTEIN S100B;

ALEXANDER DISEASE; ALZHEIMER DISEASE; ARTICLE; ASTHENIA; ASTROCYTOSIS; ATROPHY; AUTISM; BRAIN TOXICITY; CEREBROVASCULAR ACCIDENT; EPILEPSY; GLIA; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; IMMUNITY; ISCHEMIA; MAJOR DEPRESSION; MENTAL DISEASE; MICROGLIA; NERVE DEGENERATION; NEUROGLIAL REACTIVITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NIEMANN PICK DISEASE; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PARKINSON DISEASE; SCHIZOPHRENIA; SYNAPSE; SYNAPTOGENESIS;

EID: 84906976998     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Kettenmann H, Verkhratsky A 2008 Neuroglia: the 150 years after. Trends Neurosci 31: 653-659
2. Virchow R 1856 Gesammelte Abhandlungen zyr wissenschaft-lischen Medizin. Verlag von Meidinger Sohn & Comp, Frankfurt a.M.
3. Virchow R 1858 Die Cellularpathologie in ihrer Begründung auf physiologische and pathologische Gewebelehre. Zwanzig Vorlesungen gehalten während der Monate Februar, März und April 1858 im pathologischen Institut zu Berlin., First edition Edition. Berlin: August Hirschwald.
4. Verkhratsky A, Butt AM 2013 Glial Physiology and Pathophysiology. Wiley-Blackwell, Chichester.
5. Lenhossék MV 1895 Der feinere Bau des Nervensystems im Lichte neuester Forschung, 2nd edition. Berlin: Fischer's Medicinische Buchhandlung H. Kornfield.
6. Del Río-Hortega P 1921 Estudios sobre la neuroglia. La glia de escasas radiaciones oligodendroglia. Biol Soc Esp Biol 21: 64-92
7. Stallcup W B 1981 The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain. Dev Biol 83: 154-165
8. Del Río-Hortega P 1919 Poder fagocitario y movilidad de la microglia. Bol de la Soc esp de biol 9: 154
9. Del Río-Hortega P 1932 Microglia. In: Cytology and cellular pathology of the nervous system, Penfield W (ed). Hoeber. New York, p 482-534
10. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero E G, Wieghofer P, Heinrich A, Riemke P, Holscher C, Muller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M 2013 Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16: 273-280
11. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway S J, Ng LG, Stanley E R, Samokhvalov I M, Merad M 2010 Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845
12. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A 2011 Physiology of microglia. Physiol Rev 91: 461-553
13. Kettenmann H, Kirchhoff F, Verkhratsky A 2013 Microglia: new roles for the synaptic stripper. Neuron 77: 10-18
14. Kettenmann H, Ransom B R (eds) 2013 Neuroglia. Oxford University Press, Oxford.
15. Parpura V, Heneka M T, Montana V, Oliet S H, Schousboe A, Haydon P G, Stout R F Jr., Spray D C, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A 2012 Glial cells in (patho)physiology. J Neurochem 121: 4-27
16. Gourine A V, Kasparov S 2011 Astrocytes as brain interoceptors. Exp Physiol 96: 411-416
17. Yamazaki Y, Hozumi Y, Kaneko K, Fujii S, Goto K, Kato H 2010 Oligodendrocytes: facilitating axonal conduction by more than myelination. Neuroscientist 16:11-18
18. Du Y, Dreyfus C F 2002 Oligodendrocytes as providers of growth factors. J Neurosci Res 68: 647-654.
19. Fields R D 2008 Oligodendrocytes changing the rules: action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist 14: 540-543
20. Suh S W, Bergher J P, Anderson C M, Treadway J L, Fosgerau K, Swanson R A 2007 Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmet hyl) propyl]-1H-indole-2-carboxamide). J Pharmacol Exp Ther 321: 45-50
21. Verkhratsky A, Rodriguez J J, Parpura V 2013 Astroglia in neurological diseases. Future Neurol 8:149-158
22. Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A 2007 Glia: the fulcrum of brain diseases. Cell Death Differ 14:1324-1335
23. Pekny M, Nilsson M 2005 Astrocyte activation and reactive gliosis. Glia 50: 427-434
24. Sofroniew M V 2009 Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647
25. Hanisch U K, Kettenmann H 2007 Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394
26. Burda J E, Sofroniew M V 2014 Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81: 229-248
27. Pekna M, Pekny M 2012 The neurobiology of brain injury. Cerebrum 2012: 9
28. Pekny M, Wilhelmsson U, Pekna M 2014 The dual role of astrocyte activation and reactive gliosis. Neurosci Lett.
29. Robel S, Berninger B, Gotz M 2011 The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 12: 88-104
30. Bushong E A, Martone M E, Jones Y Z, Ellisman M H 2002 Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22:183-192
31. Sofroniew M V, Vinters H V 2010 Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35
32. Tripathi R B, Rivers L E, Young K M, Jamen F, Richardson W D 2010 NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 30: 16383-16390
33. Zawadzka M, Rivers L E, Fancy S P, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson W D, Franklin R J 2010 CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6: 578-590
34. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB 2005 ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758
35. Nimmerjahn A, Kirchhoff F, Helmchen F 2005 Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
36. Ransohoff R M, Perry V H 2009 Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119-145
37. Rodriguez J J, Verkhratsky A 2011 Neuroglial roots of neurodegenerative diseases? Mol Neurobiol 43: 87-96
38. De Keyser J, Mostert J P, Koch M W 2008 Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 267: 3-16
39. Alexander W S 1949 Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72: 373-381
40. Messing A, Brenner M, Feany M B, Nedergaard M, Goldman J E 2012 Alexander disease. J Neurosci 32: 5017-5023
41. Zeidan-Chulia F, Salmina A B, Malinovskaya N A, Noda M, Verkhratsky A, Moreira J C 2014 The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 38: 160-172
42. Pfrieger F W 2010 Role of glial cells in the formation and maintenance of synapses. Brain Res Rev 63: 39-46
43. Tierney E, Bukelis I, Thompson R E, Ahmed K, Aneja A, Kratz L, Kelley R I 2006 Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 141B: 666-668
44. Wei H, Mori S, Hua K, Li X 2012 Alteration of brain volume in IL-6 overexpressing mice related to autism. Int J Dev Neurosci 30: 554-559
45. Maezawa I, Jin L W 2010 Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30: 5346-5356
46. Maezawa I, Swanberg S, Harvey D, LaSalle J M, Jin L W 2009 Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 29: 5051-5061
47. Chen S K, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, Capecchi M R 2010 Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141: 775-785
48. Struys-Ponsar C, Guillard O, van den Bosch de Aguilar P 2000 Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity. Exp Neurol 163:157-164
49. Suarez-Fernandez M B, Soldado A B, Sanz-Medel A, Vega J A, Novelli A, Fernandez-Sanchez M T 1999 Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res 835:125-136
50. Yin Z, Milatovic D, Aschner J L, Syversen T, Rocha J B, Souza D O, Sidoryk M, Albrecht J, Aschner M 2007 Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res 1131: 1-10
51. Rose C F, Verkhratsky A, Parpura V 2013 Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41:1518-1524
52. Brusilow S W, Koehler R C, Traystman R J, Cooper A J 2010 Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7: 452-470
53. Butterworth R F 2011 Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53: 1372-1376
54. Takano T, Oberheim N, Cotrina M L, Nedergaard M 2009 Astrocytes and ischemic injury. Stroke 40: S8-S12
55. Vangeison G, Rempe D A 2009 The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist 15: 579-588
56. Zhao Y, Rempe D A 2010 Targeting astrocytes for stroke therapy. Neurotherapeutics 7: 439-451
57. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N 1999 Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28: 85-96
58. Lin J H, Weigel H, Cotrina M L, Liu S, Bueno E, Hansen AJ, Hansen T W, Goldman S, Nedergaard M 1998 Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1: 494-500
59. Kondziella D, Brenner E, Eyjolfsson EM, Sonnewald U 2007 How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Neurochem Int 50: 291-301.
60. Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein H G, Myint AM 2012 Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J Biol Psychiatry 13: 482-492
61. Verkhratsky A, Rodriguez J J, Steardo L 2013 Astrogliopathology: A Central Element of Neuropsychiatric Diseases? Neuroscientist.
62. Guidetti P, Hoffman G E, Melendez-Ferro M, Al-buquerque E X, Schwarcz R 2007 Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55: 78-92
63. Alexander K S, Wu H Q, Schwarcz R, Bruno J P 2012 Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the a7 positive modulator galantamine. Psychopharmacology (Berl) 220: 627-637
64. Schwarcz R, Hunter C A 2007 Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid? Schizophr Bull 33: 652-653
65. Oberheim N A, Tian G F, Han X, Peng W, Takano T, Ransom B, Nedergaard M 2008 Loss of astrocytic domain organization in the epileptic brain. J Neurosci 28: 3264-3276
66. Carmignoto G, Haydon P G 2012 Astrocyte calcium signaling and epilepsy. Glia 60: 1227-1233.
67. Coulter D A, Eid T 2012 Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60: 1215-1226.
68. Seifert G, Carmignoto G, Steinhauser C 2010 Astrocyte dysfunction in epilepsy. Brain Res Rev 63: 212-221
69. Seifert G, Steinhauser C 2011 Neuron-astrocyte signaling and epilepsy. Exp Neurol.
70. Gotz J, Streffer J R, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F 2004 Transgenic animal models of Alzheimer’s disease and related disorders: histo-pathology, behavior and therapy. Mol Psychiatry 9: 664-683
71. Gotz J, Matamales M, Gotz NN, Ittner LM, Eckert A 2012 Alzheimer’s disease models and functional genomics-How many needles are there in the haystack? Front Physiol 3: 320
72. Acevedo-Arozena A, Kalmar B, Essa S, Ricketts T, Joyce P, Kent R, Rowe C, Parker A, Gray A, Hafezparast M, Thorpe J R, Greensmith L, Fisher E M 2011 A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. Dis Model Mech 4: 686-700
73. Skaper S D, Giusti P 2010 Transgenic mouse models of Parkinson’s disease and Huntington’s disease. CNS Neurol Disord Drug Targets 9: 455-470
74. Rossi D, Brambilla L, Valori CF, Roncoroni C, Crugnola A, Yokota T, Bredesen DE, Volterra A 2008 Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ 15: 1691-1700
75. Staats K A, Van Den Bosch L 2009 Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J Biol Phys 35: 337-346
76. Wang L, Gutmann D H, Roos R P 2011 Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet 20: 286-293
77. Yamanaka K, Chun S J, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann D H, Takahashi R, Misawa H, Cleveland D W 2008 Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253
78. Korsakoff S S, (psychosis polineuritica, s. cerebropathia psychica toxaemica). English translation: Korsakoff, S. S. Psychic disorder in conjunction with multiple neuritis, Translated from Russian by Victor, M. and Yakovlev, Neurology (1955), 5: 394 - 406. 32:3-18
79. Wernicke C 1881 - 1883 Lehrbuch der Gehirnkrankheiten für Aerzte und Studirende. Theodor Fischer, Kassel und Berlin.
80. Hazell A S 2009 Astrocytes are a major target in thiamine deficiency and Wernicke’s encephalopathy. Neurochem Int 55:129-135
81. Hazell A S, Sheedy D, Oanea R, Aghourian M, Sun S, Jung JY, Wang D, Wang C 2009 Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia 58:148-156
82. Braak H, de Vos R A, Jansen E N, Bratzke H, Braak E 1998 Neuropathological hallmarks of Alzheimer’s and Parkinson’s diseases. Prog Brain Res 117: 267-285
83. Selkoe D J 2001 Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741-766
84. Rodriguez J J, Olabarria M, Chvatal A, Verkhratsky A 2009 Astroglia in dementia and Alzheimer’s disease. Cell Death Differ 16: 378-385
85. Verkhratsky A, Olabarria M, Noristani H N, Yeh C Y, Rodriguez J J 2010 Astrocytes in Alzheimer’s disease. Neurotherapeutics (in press)
86. Beauquis J, Vinuesa A, Pomilio C, Pavia P, Galvan V, Saravia F 2014 Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer’s disease. Hippocampus 24:257-269.
87. Beauquis J, Pavia P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V, Saravia F 2013 Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer’s disease. Exp Neurol 239: 28-37
88. Rodriguez J J, Terzieva S, Olabarria M, Lanza R G, Verkhratsky A 2013 Enriched environment and physical activity reverse astrogliodegeneration in the hippocampus of AD transgenic mice. Cell Death Dis 4: e678
89. Kulijewicz-Nawrot M, Verkhratsky A, Chvatal A, Sykova E, Rodriguez J J 2012 Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease. J Anat 221: 252-262
90. Yeh C Y, Vadhwana B, Verkhratsky A, Rodriguez J J 2011 Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer’s disease. ASN Neuro 3: 271-279
91. Olabarria M, Noristani H N, Verkhratsky A, Rodriguez J J 2010 Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease. Glia 58: 831-838
92. Rush T, Buisson A 2014 Reciprocal disruption of neuronal signaling and Abeta production mediated by extrasynaptic NMDA receptors: a downward spiral. Cell Tissue Res.
93. Olabarria M, Noristani H N, Verkhratsky A, Rodriguez J J 2011 Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer’s disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegener 6: 55
94. Kuchibhotla K V, Lattarulo C R, Hyman B T, Bacskai B J 2009 Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323: 1211-1215
95. Gagyi E, Kormos B, Castellanos K J, Valyi-Nagy K, Korneff D, LoPresti P, Woltjer R, Valyi-Nagy T 2012 Decreased oligodendrocyte nuclear diameter in Alzheimer’s disease and Lewy body dementia. Brain Pathol 22: 803-810
96. Behrendt G, Baer K, Buffo A, Curtis M A, Faull R L, Rees M I, Gotz M, Dimou L 2013 Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61: 273-286
97. Rodriguez J J, Noristani H N, Verkhratsky A 2013 Microglial response to Alzheimer’s disease is differentially modu lated by voluntary wheel running and enriched environments. Brain Struct Funct.
98. Rodriguez J J, Witton J, Olabarria M, Noristani H N, Verkhratsky A 2010 Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer’s disease. Cell Death Dis 1: e1.
99. Peters O, Schipke C G, Philipps A, Haas B, Pannasch U, Wang L P, Benedetti B, Kingston A E, Kettenmann H 2009 Astrocyte function is modified by Alzheimer’s disease-like pathology in aged mice. J Alzheimers Dis 18: 177-189
100. Broe M, Kril J, Halliday G M 2004 Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127: 2214-2220
101. Kersaitis C, Halliday G M, Kril J J 2004 Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 108: 515-523
102. Potts R, Leech R W 2005 Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. Clin Neuropathol 24: 271-275
103. Rosenbaum A I, Maxfield F R 2011 Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem 116: 789-795
104. Estrada-Sánchez A M, Rebec G V 2012 Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington’s disease: Interactions between neurons and astrocytes. Basal Ganglia (in press)
105. 2+-dependent glutamate release from astrocytes of the BACHD Huntington’s disease mouse model. Neurobiol Dis 58: 192-199
106. McGeer P L, McGeer E G 2008 Glial reactions in Parkinson’s disease. Mov Disord 23: 474-483